Edition:
United States

Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Global Market

0.90USD
14 Dec 2017
Change (% chg)

$-0.01 (-1.15%)
Prev Close
$0.91
Open
$0.91
Day's High
$0.95
Day's Low
$0.89
Volume
95,619
Avg. Vol
118,491
52-wk High
$2.75
52-wk Low
$0.79

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.14 December 15 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 0 0 0 0
(3) HOLD 5 5 5 5
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.67 2.67 2.67 2.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 4 0.03 0.10 0.00 1.67
Quarter Ending Mar-18 2 5.30 10.60 0.00 --
Year Ending Dec-17 5 0.89 4.00 0.05 7.63
Year Ending Dec-18 5 12.40 52.90 0.00 6.84
Earnings (per share)
Quarter Ending Dec-17 5 -0.14 -0.12 -0.19 -0.37
Quarter Ending Mar-18 3 -0.09 -0.04 -0.12 --
Year Ending Dec-17 5 -0.99 -0.93 -1.15 -1.42
Year Ending Dec-18 5 -0.39 -0.09 -0.52 -1.62

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.86 0.02 0.85 97.92
Quarter Ending Jun-17 0.87 0.02 0.85 97.94
Quarter Ending Mar-17 0.94 0.02 0.93 98.09
Quarter Ending Dec-16 0.92 0.02 0.90 98.04
Quarter Ending Sep-16 1.20 0.20 0.99 82.97
Earnings (per share)
Quarter Ending Sep-17 -0.16 -0.18 0.02 -11.32
Quarter Ending Jun-17 -0.33 -0.41 0.08 -23.72
Quarter Ending Mar-17 -0.34 -0.38 0.03 -10.14
Quarter Ending Dec-16 -0.37 -0.38 0.01 -3.91
Quarter Ending Sep-16 -0.40 -0.37 0.03 -7.04

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 0.03 1.10 0.88 0.92 1.67
Quarter Ending Mar-18 5.30 5.30 3.53 5.30 --
Year Ending Dec-17 0.89 1.09 0.89 1.82 7.63
Year Ending Dec-18 12.40 15.48 12.40 12.60 6.84
Earnings (per share)
Quarter Ending Dec-17 -0.14 -0.15 -0.15 -0.16 -0.37
Quarter Ending Mar-18 -0.09 -0.08 -0.09 -0.11 --
Year Ending Dec-17 -0.99 -1.00 -0.98 -0.96 -1.42
Year Ending Dec-18 -0.39 -0.37 -0.39 -0.40 -1.62

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 1
Year Ending Dec-18 0 0 1 1